Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión) Open Journal Systems
Estudio de la clonalidad linfoide por medio del análisis de reordenamientos del receptor de antígeno
Resumen
Las proliferaciones linfoides malignas suelen ser clonales. La mayoría de las veces el potencial biológico de una lesión se establece por medio del análisis clínico y el estudio anatomopatológico, pero algunos casos son de difícil diagnóstico. Por otra parte, existen situaciones en las cuales se producen clones dominantes cuyo análisis es importante, tal como ocurre en enfermedades autoinmunes e inmunodeficiencias. Este artículo presenta de manera comprensible las técnicas principales para el estudio de la clonalidad en lesiones linfoides, es decir, el análisis de reordenamientos de genes del receptor de antígeno por medio de pruebas basadas en reacción en cadena de la polimerasa (PCR) multiplex.
Palabras clave
Referencias
Greaves M, Maley CC. Clonal evolution in cancer. Nature 2012;481(10762):306-13.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Fourth Edition, Lyon, France: WHO; 2008.
Jaffe E, Lee-Harris N, Vardiman J, Campo E, Arber DA.
Van Dongen JJM, Langerak AW, Brüggemann M, Evans PAS, Hummel M, Lavender Fl, et al. Design and standarization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-317.
Perfetti V, Brunetti L, Biagi F, Ciccocioppo R, Bianchi PI, Corazza GR. TCRβ clonality improves diagnostic yield of TCRγ clonality in refractory celiac disease. J Clin Gastroenterol. 2012;46(8):675-9.
Sirsath NT, Channaviriappa L, Nagendrappa LK, Dasappa L, Sathyanarayanan V, Setty GB. Human immunodeficiency virus – associated lymphomas: a neglected domain. N Am J Med Sci. 2013;5(7):432-7.
Abbas AK. Inmunología celular y molecular. Ninth edition: San Francisco, USA: El Sevier; 2009.
Giallourakis CC, Franklin A, Guo C, Cheng HL, Yoon HS, Gallagher M, et al. Elements between the IgH variable (V) and diversity (D) clusters influence antisense transcription and lineage-specificV(D)J recombination. Proc Natl Acad Sci USA. 2010;107(51):22207-12.
Deriano L, Chaumeil J, Coussen M, Multani A, Chou YF, Alekseyenko AV, et al. The RAG2 C-terminus suppresses genomic instability and lymphomagenesis. Nature. 2011;471(7336):119-23.
Knowles II DM, Neri A, Pelicci PG, Burke JS, Wu A, Winberg CD, et al. Immunoglobulin and T-cell receptor B-chain gene rearrangement analysys of Hodgkin’s Disease: Implications for lone age determination and differential diagnosis. Proc Natl Acad Sci USA. 1986;83(1):7942-6.
EuroClonality. EuroClonality 2013 [Consultado el 10 de octubre de 2013]. Disponible en http://www.euroclonality.org/
Invivoscribe. Invivoscribe | Personalized Molecular Medicine 20. [Consultado el 28 de octubre de 2013). Disponible en http://www.invivoscribe.com/
Melotti CZ, Carriel MF, Sotto MN, Diss T, Sanches JA. Polymerase Chain Reaction-Based Clonality Analysis of Cutaneous B-Cell Lymphoproliferative Processes. Clinics. 2010;65(1):53-60.
Harris S, Bruggemann M, Groenen PJTA, Shuuring E, Langerak AW, Hodges E. Clonality analysis in lymphoproliferative disease using the BIOMED-2 multiplex PCR protocols: experience from the EuroClonality group EQA scheme. Journal of Hematopathology. 2012;5(1-2):91-8.
Van den Beemd R, Boor PP, Van Lochem EG, Hop WC, Langerak AW, Wolvers-Tettero IL, et al. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry. 2000;40(4):336-45.
Kalina T, Flores-Montero J, Van der Velden VH, Martin-Ayuso M, Böttcher S, Ritgen M, et al; EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708). EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. 2012;26(9):1986-2010.
Van Krieken JH, Cabecadas J, Groenen PJ. Clonality testing: teamwork by pathologist and molecular biologist. J Hematopathol 2012;5(1-2):3-5.
Bonzheim I, Frölich F, Adam P, Colak S, Metzler G, Fend F, et al. A comparative analysis of protocols for detection of T cell clonality in formalin-fixed, paraffin-embeddestissue- implications for practical use. Journal of Hematopathology. 2012;5(1-2):7-16.
Paireder S, Werner B, Bailer J, Werther W, Schmid E, Patzak B, et al. Comparison of protocols for DNA extraction from long-term preserved formal infixed tissues. Anal Biochem. 2013;2(439):452-60.
Van Krieken JH, Langerak AW, Macintyre EA, Kneba M, Hodges E, Sanz RG, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21(2):201-6.
Medeiros LJ, Carr J. Overview of the role of molecular methods in the diagnosis of malignant lymphomas. Arch Pathol Lab Med. 1999;123(12):1189-207.
Hebeda KM, Van Altena MC, Rombout P, Van Krieken JHJM, Groenen PJTA. PCR clonality detection in Hodgkin lymphoma. J Hematopathol 2013:34-41.
Beaufils N, Ben Lassoued A, Essaydi A, Dales JP, Formisano-Tréziny C, Bonnet N, et al. Analysis of T-cell receptor-γ gene rearrangements using heteroduplex analysis by high-resolution microcapillary electrophoresis. Leuk Res. 2012;36(9):1119-23.
Evans PA, Pott Ch, Groenen PJ, Salles G, Davi F, Berger F, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21(2):207-14.
Langerak AW, Groenen PJ, Brüggemann M, Beldjord K, Bellan C, Bonello L, et al. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lyphoproliferations. Leukemia. 2012;26(10):2159-71.
Ortiz YM, Arias L, Alvarez CM, García LF. Memory phenotype and polyfunctional T cells in kidney transplant patients. Transpl Immunol 2013;28(3):127-37.
Piña-Oviedo S, Fend F, Kramer M, Fournier F, Farca A, Ortiz-Hidalgo C. Diagnosis of early gastric marginal zone lymphoma (MALT lymphoma) in endoscopic biopsies. Report of a case that demonstrates the utility of immunohistochemistry and the molecular analysis. Rev Gastroenterol Mex. 2008;73(3):172-6.
Stefanoff CG, Hassan R, Gonzalez AC, Andrade LA, Tabak DG, Romano S, et al. Diagn Mol Pathol. 2003;12(2):79-87.
Bosaleh A, Denninghoff V, García A, Rescia C, Avagnina A, Elsner B. Rearreglos de genes de cadenas pesadas de las inmunoglobulinas en las gammapatias monoclonales.
Quesnel B, Preudhomme C. Residual disease: the hematologist’s point of view. Bull Cancer. 2001;88(6):571-5.
Garand R, Beldjord K, Cavé H, Fossat C, Arnoux I, Asnafi V, et al. Flowcytometry and IG/TCR quantitative PCR for minimal residual disease quantification in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL. Leukemia 2013;27(2):370-6.
Van Dongen JJ, Seriu T, Panzer-Grümayer ER, Biondi A, Pongers-Willemse MJ, Corral L, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet. 1998;352(9142):1731-8.
Cavé H, Van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer—Childhood Leukemia Cooperative Group. N Engl J Med. 1998;339(9):591-8.
Weng XQ, Shen Y, Sheng Y, Chen B, Wang JH, Li JM. Prognostic significance of monitoring leukemia-associated immuniphenotypes by eight-color flowcytometry in adult B-acute lymphoblastic leukemia. Blood Cancer J. 2013;16(3):133-43.
Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, et al. Estandardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia 2010;24(3):521-535.
Enlaces refback
- No hay ningún enlace refback.